Cargando…
Circulating Tumour DNA in Muscle-Invasive Bladder Cancer
Circulating tumour DNA (ctDNA) is an attractive tool in cancer research, offering many advantages over tissue samples obtained using traditional biopsy methods. There has been increasing interest in its application to muscle-invasive bladder cancer (MIBC), which is recognised to be a heterogeneous d...
Autores principales: | Tan, Melissa P., Attard, Gerhardt, Huddart, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165229/ https://www.ncbi.nlm.nih.gov/pubmed/30158468 http://dx.doi.org/10.3390/ijms19092568 |
Ejemplares similares
-
A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer
por: Portner, R., et al.
Publicado: (2021) -
Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
por: Beije, N., et al.
Publicado: (2022) -
The current role of circulating biomarkers in non-muscle invasive bladder cancer
por: Rink, Michael, et al.
Publicado: (2019) -
Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer
por: Semeniuk-Wojtaś, Aleksandra, et al.
Publicado: (2023) -
Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)